<DOC>
	<DOCNO>NCT00931268</DOCNO>
	<brief_summary>The study undertaken establish effectiveness safety Macrolane volume restoration factor 30 ( VRF30 ) use treatment HIV-infected subject buttocks lipoatrophy .</brief_summary>
	<brief_title>Morphological Functional Evaluation Buttock Lipoatrophy Treatment With Macrolane</brief_title>
	<detailed_description />
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<criteria>Have buttock lipoatrophy unable remain seat 30 minute due pain . Have undergone HIV treatment 2 year . Have RNA copy less 50/ml . Have CD4 200 cell/mm3 . Active infection . Active skin disease , inflammation related condition . Perineal pathology . Condition may affect pain assessment . Skin underlie fibrous tissue . BMI le 19 . Insufficient tissue cover area treat . Concomitant anticoagulant therapy therapy inhibitor platelet aggregation within 14 day prior treatment , history bleeding disorder . Permanent implant place treatment area . Other injectable implant , liposuction surgical therapy treatment area . Presence history connective tissue disease . Tumors premalign tissue disorder near area treat . Contraindications MRI Previous hypersensitivity hyaluronic acid , local anesthetic antibiotic use study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Lipoatrophy</keyword>
	<keyword>Buttock treatment</keyword>
</DOC>